Healthcare provider profile · identity verified

Michelle Corcoran, FNP-BC

Nurse Practitioner · DENVER, CO · NPI 1316354285

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	65
Gabapentin	Gabapentin	218	33
Furosemide	Furosemide	190	37
Amlodipine Besylate	Amlodipine Besylate	186	42
Levothyroxine Sodium	Levothyroxine Sodium	152	22
Potassium Chloride	Potassium Chloride	151	24
Metoprolol Succinate	Metoprolol Succinate	147	28
Pantoprazole Sodium	Pantoprazole Sodium	115	22
Losartan Potassium	Losartan Potassium	106	20
Trazodone Hcl	Trazodone Hcl	95	19
Simvastatin	Simvastatin	94	12
Metformin Hcl	Metformin Hcl	93	13
Lisinopril	Lisinopril	92	20
Omeprazole	Omeprazole	90	17
Alendronate Sodium	Alendronate Sodium	89	16
Sertraline Hcl	Sertraline Hcl	89	15
Duloxetine Hcl	Duloxetine Hcl	84	14
Levetiracetam	Levetiracetam	81	11
Quetiapine Fumarate	Quetiapine Fumarate	81	14
Olanzapine	Olanzapine	80	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	73	13
Tamsulosin Hcl	Tamsulosin Hcl	71	14
Donepezil Hcl	Donepezil Hcl	67	suppressed
Divalproex Sodium	Divalproex Sodium	65	11
Escitalopram Oxalate	Escitalopram Oxalate	65	11
Albuterol Sulfate Hfa	Albuterol Sulfate	63	27
Buspirone Hcl	Buspirone Hcl	62	suppressed
Eliquis	Apixaban	59	17
Famotidine	Famotidine	57	15
Prednisone	Prednisone	57	20
Carvedilol	Carvedilol	56	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	20
Baclofen	Baclofen	52	11
Latanoprost	Latanoprost	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	49	suppressed
Aripiprazole	Aripiprazole	46	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Bumetanide	Bumetanide	42	suppressed
Lamotrigine	Lamotrigine	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Mirtazapine	Mirtazapine	38	13
Pregabalin	Pregabalin	38	suppressed
Risperidone	Risperidone	38	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	38	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	suppressed
Spironolactone	Spironolactone	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Ibuprofen	Ibuprofen	33	12
Spiriva Respimat	Tiotropium Bromide	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	29	suppressed
Mirabegron Er	Mirabegron	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Cyclosporine	Cyclosporine	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Primidone	Primidone	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	11
Fluticasone Propionate	Fluticasone Propionate	23	15
Lorazepam	Lorazepam	23	13
Tramadol Hcl	Tramadol Hcl	23	suppressed
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Lumigan	Bimatoprost	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Anastrozole	Anastrozole	21	suppressed
Dapagliflozin	Dapagliflozin Propanediol	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Roflumilast	Roflumilast	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Liraglutide	Liraglutide	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Lactulose	Lactulose	17	suppressed
Topiramate	Topiramate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Januvia	Sitagliptin Phosphate	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Pregabalin Er	Pregabalin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Atenolol	Atenolol	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cephalexin	Cephalexin	14	12
Finasteride	Finasteride	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Rhopressa	Netarsudil Mesylate	13	suppressed
Valsartan	Valsartan	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Azithromycin	Azithromycin	12	12
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Linzess	Linaclotide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error